These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26236932)

  • 1. [Effect of neutrophil gelatinase-associated lipocalin on prognosis of patients with type 2 hepatorenal syndrome].
    Zhang Z; Wu L; Chen X; Chen L; Wang G; Yan H
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):449-53. PubMed ID: 26236932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil gelatinase-associated lipocalin in prediction of mortality in patients with hepatorenal syndrome: a prospective observational study.
    Gungor G; Ataseven H; Demir A; Solak Y; Gaipov A; Biyik M; Ozturk B; Polat I; Kiyici A; Cakir OO; Polat H
    Liver Int; 2014 Jan; 34(1):49-57. PubMed ID: 23799980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis.
    Fagundes C; Pépin MN; Guevara M; Barreto R; Casals G; Solà E; Pereira G; Rodríguez E; Garcia E; Prado V; Poch E; Jiménez W; Fernández J; Arroyo V; Ginès P
    J Hepatol; 2012 Aug; 57(2):267-73. PubMed ID: 22521351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections.
    Barreto R; Elia C; Solà E; Moreira R; Ariza X; Rodríguez E; Graupera I; Alfaro I; Morales-Ruiz M; Poch E; Guevara M; Fernández J; Jiménez W; Arroyo V; Ginès P
    J Hepatol; 2014 Jul; 61(1):35-42. PubMed ID: 24613364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
    Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
    Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
    Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is neutrophil gelatinase-associated lipocalin an optimal marker of renal function and injury in liver transplant recipients?
    Hryniewiecka E; Gala K; Krawczyk M; Pączek L
    Transplant Proc; 2014 Oct; 46(8):2782-5. PubMed ID: 25380917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.
    Ariza X; Graupera I; Coll M; Solà E; Barreto R; García E; Moreira R; Elia C; Morales-Ruiz M; Llopis M; Huelin P; Solé C; Fabrellas N; Weiss E; Nevens F; Gerbes A; Trebicka J; Saliba F; Fondevila C; Hernández-Gea V; Fernández J; Bernardi M; Arroyo V; Jiménez W; Deulofeu C; Pavesi M; Angeli P; Jalan R; Moreau R; Sancho-Bru P; Ginès P;
    J Hepatol; 2016 Jul; 65(1):57-65. PubMed ID: 26988732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil gelatinase-associated lipocalin (NGAL) in heart transplant recipients after conversion to everolimus therapy.
    Stypmann J; Fobker M; Rosing K; Engelen M; Gunia S; Dell'Aquila AM; Nofer JR
    J Cardiol; 2015 Oct; 66(4):347-52. PubMed ID: 25583090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Park GY; Yu CH; Kim JS; Kang YJ; Kwon O; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Korean J Intern Med; 2015 May; 30(3):345-53. PubMed ID: 25995665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
    Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis.
    Lindberg S; Jensen JS; Mogelvang R; Pedersen SH; Galatius S; Flyvbjerg A; Magnusson NE
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2135-42. PubMed ID: 24969771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.
    Elsharawy S; Raslan L; Morsy S; Hassan B; Khalifa N
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):49-54. PubMed ID: 26787566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil gelatinase-associated lipocalin associated with irreversibility of pre-liver transplant kidney dysfunction.
    Aberg F; Lempinen M; Hollmén M; Nordin A; Mäkisalo H; Isoniemi H
    Clin Transplant; 2014 Aug; 28(8):869-76. PubMed ID: 24930480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
    Przybylowski P; Malyszko J; Malyszko JS
    Transplant Proc; 2010 Jun; 42(5):1797-802. PubMed ID: 20620526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of neutrophil gelatinase-associated lipocalin in normoalbuminuric normotensive type 1 diabetic adolescents.
    Demir K; Abaci A; Küme T; Altincik A; Catli G; Böber E
    J Pediatr Endocrinol Metab; 2012; 25(5-6):517-23. PubMed ID: 22876548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma neutrophil gelatinase-associated lipocalin (NGAL) correlations with cystatin C, serum creatinine, and glomerular filtration rate in patients after heart and lung transplantation.
    Szewczyk M; Wielkoszyński T; Zakliczyński M; Zembala M
    Transplant Proc; 2009 Oct; 41(8):3242-3. PubMed ID: 19857721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.